|
(Health-NewsWire.Net, July 09, 2015 ) Osteoarthritis is a disease which is caused by ebbing of the joint cartilage and the formation of new bone at the joints. There are number of Drugs and medications to cover it. A-889425, ADX-71441, Ampion, AS-288640100 are some of the Drugs Profile which are Included in this Report.
The Company Mentioned in this report Is Addex Therapeutics Ltd, Afferent Pharmaceuticals, Inc, Ampio Pharmaceuticals, Inc., Antibe Therapeutics, Inc., Bone Medical Limited, etc
Inquire more about this Report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=394554 . (This is a premium report price at US$2000 for a single user PDF license)
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
This report provides comprehensive information on the therapeutic development for Osteoarthritis Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoarthritis Pain and special features on late-stage and discontinued projects.
Scope:
• The report provides a snapshot of the global therapeutic landscape of Osteoarthritis Pain
• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in the therapeutics development for Osteoarthritis Pain and enlists all their major and minor projects
• The report summarizes all the dormant and discontinued pipeline projects
• A review of the Osteoarthritis Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Inquire for discount on this report at http://www.rnrmarketresearch.com/contacts/discount?rname=394554 . (This is a premium report price at US$2000 for a single user PDF license)
Reasons to Buy:
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop strategic initiatives by understanding the focus areas of leading companies
• Identify and understand important and diverse types of therapeutics under development for Osteoarthritis Pain
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Devise corrective measures for pipeline projects by understanding Osteoarthritis Pain pipeline depth and focus of Indication therapeutics
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
More reports on Pain Management Market Research Reports are available at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/pain-management .
RnR Market Research
Ritesh Tiwari
+ 1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
